Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma.

Wu Q, Liu Y, Ren Y, Xu X, Yu L, Li Y, Quan C.

Eur J Cancer Prev. 2010 May;19(3):186-94. doi: 10.1097/CEJ.0b013e328337210e.

PMID:
20215972
2.

[Effects of stable up-regulation of tight junction protein claudin-6 upon biological phenotypes of breast cancer cell MCF-7].

Wu Q, Liu YF, Ren Y, Xu XM, Yu LN, Li YL, Quan CS.

Zhonghua Yi Xue Za Zhi. 2010 Feb 9;90(6):407-12. Chinese.

PMID:
20367941
3.

Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells.

Osanai M, Murata M, Chiba H, Kojima T, Sawada N.

Cancer Sci. 2007 Oct;98(10):1557-62. Epub 2007 Jul 23.

4.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

5.

Claudin-16 reduces the aggressive behavior of human breast cancer cells.

Martin TA, Harrison GM, Watkins G, Jiang WG.

J Cell Biochem. 2008 Sep 1;105(1):41-52. doi: 10.1002/jcb.21797.

PMID:
18442037
6.

Expression and function of tight junction associated molecules in human breast tumor cells is not affected by the Ras-MEK1 pathway.

Macek R, Swisshelm K, Kubbies M.

Cell Mol Biol (Noisy-le-grand). 2003 Feb;49(1):1-11.

PMID:
12839332
7.

Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.

Clin Cancer Res. 2005 Jun 15;11(12):4357-64.

8.

Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells.

Korah RM, Sysounthone V, Golowa Y, Wieder R.

Cancer Res. 2000 Feb 1;60(3):733-40.

9.

Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.

Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ.

Breast Cancer Res Treat. 2009 Feb;113(3):443-56. doi: 10.1007/s10549-008-9956-x. Epub 2008 Mar 10.

PMID:
18327707
10.

Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S.

Oncogene. 2003 Apr 3;22(13):2021-33.

PMID:
12673207
11.

Claudin-11 decreases the invasiveness of bladder cancer cells.

Awsare NS, Martin TA, Haynes MD, Matthews PN, Jiang WG.

Oncol Rep. 2011 Jun;25(6):1503-9. doi: 10.3892/or.2011.1244. Epub 2011 Apr 4.

PMID:
21468549
12.

Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer.

Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Löhr M, Leder G, Iwamura T, Adler G, Gress TM.

Cancer Res. 2003 Oct 1;63(19):6265-71.

14.

Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.

Han G, Fan B, Zhang Y, Zhou X, Wang Y, Dong H, Wei Y, Sun S, Hu M, Zhang J, Wei L.

Oncol Rep. 2008 Oct;20(4):929-39.

PMID:
18813837
16.

[Correlation of expression of RhoC with invasiveness of breast cancer cells in vitro].

Yuan Z, Su J, You JF, Wang JL, Cui XL, Zheng J.

Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):898-903. Chinese.

PMID:
18478927
17.

Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis.

McLeskey SW, Zhang L, Kharbanda S, Kurebayashi J, Lippman ME, Dickson RB, Kern FG.

Breast Cancer Res Treat. 1996;39(1):103-17.

PMID:
8738610
18.

Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells.

Amasheh S, Schmidt T, Mahn M, Florian P, Mankertz J, Tavalali S, Gitter AH, Schulzke JD, Fromm M.

Cell Tissue Res. 2005 Jul;321(1):89-96.

PMID:
16158492
19.
20.

[Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].

Kang CS, Pu PY, Wang GX, Li YH, Dong L, Wang H.

Zhonghua Yi Xue Za Zhi. 2004 Sep 17;84(18):1503-8. Chinese.

PMID:
15500708

Supplemental Content

Support Center